Versenate (Edetate Calcium Disodium) - Summary

VERSENATE SUMMARY

Calcium Disodium Versenate (edetate calcium disodium injection, USP) is a sterile, injectable, chelating agent in concentrated solution for intravenous infusion or intramuscular injection. Each 5 ml ampul contains 1000 mg of edetate calcium disodium (equivalent to 200 mg/ml) in water for injection.

Edetate calcium disodium is indicated for the reduction of blood levels and depot stores of lead in lead poisoning (acute and chronic) and lead encephalopathy, in both pediatric populations and adults. Chelation therapy should not replace effective measures to eliminate or reduce further exposure to lead.

VERSENATE NEWS HIGHLIGHTS

Published Studies Related to Versenate (Edetate Calcium Disodium)

A randomised double-blind study comparing sodium feredetate with ferrous fumarate in anaemia in pregnancy. [2007.05]

Microbial growth in propofol formulations with disodium edetate and the influence of venous access system dead space. [2007.06]

Deaths resulting from hypocalcemia after administration of edetate disodium: 2003-2005. [2006.08]

[Visual evoked potentials in children cured with sodium-calcium versenate because of high blood lead level--the prospective study] [2005]

more>>

Clinical Trials Related to Versenate (Edetate Calcium Disodium)

Long-Term Lead Chelation Therapy and Progressive Renal Insufficiency [Completed]

Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection [Completed]

Environmental Exposure to Lead and Progressive Renal Insufficiency in Type II Diabetic Nephropathy [Recruiting]

more>>